Although an uncommon location, cutaneous mucinoses may present in the pretibial area in distinct clinical circumstances. The terms pretibial myxedema and pretibial mucinosis often are used interchangeably, but pretibial myxedema should be regarded as a type of pretibial mucinosis. We present a case of cutaneous mucinosis localized to the pretibial area of a patient without Graves disease.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Pretibial Myxedema as the Presenting Manifestation of Graves Disease.
Am J Med
October 2024
Department of Dermatology, Venereology and Leprosy, RG Kar Medical College, Kolkata, India.
Graves' disease thyroid dermopathy: a case report.
J Med Case Rep
April 2024
Department of Pediatrics, King Faisal Specialist Hospital and Research Centre, Al Takhassousi & 12713, 11211, Riyadh, Saudi Arabia.
Article Synopsis
- Graves' disease is an autoimmune disorder leading to thyroid gland enlargement and overactivity, with various symptoms affecting multiple organ systems, including thyroid-related skin conditions.
- The case presented involves an 11-year-old boy from Saudi Arabia with symptoms like goiter and bulging eyes, alongside unusual swelling and nodules on his body that resembled a lymphatic issue.
- Treatment options including steroid injections and total thyroid removal improved the patient's condition, highlighting the rare manifestations of thyroid dermopathy in this case.
Tofacitinib Treatment for Pretibial Myxedema.
JAMA Dermatol
May 2024
Department of Dermatology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Case Report of Graves' Disease in a 45-Year-Old Woman Secondary to Herceptin Treatment for Breast Cancer.
Monoclon Antib Immunodiagn Immunother
December 2023
Department of Medicine, Endocrinology, College of Medicine, University of Lagos, Lagos, Nigeria.
Article Synopsis
- - Graves' disease is an autoimmune disorder that leads to thyrotoxicosis and often includes symptoms like eye problems (proptosis), skin changes (pretibial myxedema), and finger abnormalities (thyroid acropachy).
- - Factors contributing to Graves' disease can include genetic predisposition and environmental triggers, such as certain cancer treatments like immune checkpoint inhibitors.
- - Breast cancer cases are on the rise due to better awareness and screening, but improvements in treatment have lowered mortality rates, even though survivors may experience various side effects from these treatments.
The realistic positioning of UVA1 phototherapy after 25 years of clinical experience and the availability of new biologics and small molecules: a retrospective clinical study.
Front Med (Lausanne)
November 2023
Department of Dermatology, University of Brescia, Brescia, Italy.
Article Synopsis
- Ultraviolet (UVA) A1 phototherapy has been an effective treatment for various skin conditions since the 1990s, yet its application remains limited to a few dermatology centers even after 30 years.
- A study at a single center reviewed 740 patients treated from 1998 to 2022, assessing treatment outcomes and side effects, revealing significant improvements in several conditions, including morphea and skin sarcoidosis.
- Despite showing good efficacy, the usage of UVA1 phototherapy has decreased over the years due to multiple factors, including possible changes in clinical practices and alternatives available.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!